Envista (NVST)
(Delayed Data from NYSE)
$19.33 USD
+0.15 (0.78%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $19.33 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value C Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Envista Holdings Corporation [NVST]
Reports for Purchase
Showing records 1 - 20 ( 22 total )
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Optimized Entry and Exit Levels for NVST 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department
Company: Envista Holdings Corporation
Industry: Medical - Products
Provider: Zacks Investment Research
Analyst: Research Department